Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M PEROU

Showing results (231-240 of 476) with videos related to

Pageof 48
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|September 24, 2011
Defining the cellular precursors to human breast cancerPatricia J Keller, Lisa M Arendt, Adam Skibinski, et al.
Breast Cancer Research and Treatment|December 11, 2012
MicroRNA-30c targets cytoskeleton genes involved in breast cancer cell invasionJessica Bockhorn, Kathy Yee, Ya-Fang Chang, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 3, 2011
Comparative oncogenomics identifies breast tumors enriched in functional tumor-initiating cellsJason I Herschkowitz, Wei Zhao, Mei Zhang, et al.
Journal of the National Cancer Institute|May 14, 2009
Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancerMaggie C U Cheang, Stephen K Chia, David Voduc, et al.
Biorxiv : the Preprint Server for Biology|April 8, 2024
Generative Adversarial Networks Accurately Reconstruct Pan-Cancer Histology from Pathologic, Genomic, and Radiographic Latent FeaturesFrederick M Howard, Hanna M Hieromnimon, Siddhi Ramesh, et al.
Journal of the National Cancer Institute|April 5, 2017
Progesterone Receptor Isoform Ratio: A Breast Cancer Prognostic and Predictive Factor for Antiprogestin ResponsivenessPaola A Rojas, María May, Gonzalo R Sequeira, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 14, 2013
Mutant PIK3CA accelerates HER2-driven transgenic mammary tumors and induces resistance to combinations of anti-HER2 therapiesAriella B Hanker, Adam D Pfefferle, Justin M Balko, et al.
Science Advances|November 15, 2024
Generative adversarial networks accurately reconstruct pan-cancer histology from pathologic, genomic, and radiographic latent featuresFrederick M Howard, Hanna M Hieromnimon, Siddhi Ramesh, et al.
NPJ Breast Cancer|March 8, 2025
Prognostic and molecular multi-platform analysis of CALGB 40603 (Alliance) and public triple-negative breast cancer datasetsBrooke M Felsheim, Aranzazu Fernandez-Martinez, Cheng Fan, et al.
Plos One|May 8, 2013
Pharmacokinetics and efficacy of PEGylated liposomal doxorubicin in an intracranial model of breast cancerCarey K Anders, Barbara Adamo, Olga Karginova, et al.
Pageof 48

Showing results (231-240 of 476) with videos related to

Sort By:
Pageof 48
Proceedings of the National Academy of Sciences of the United States of America|September 24, 2011
Defining the cellular precursors to human breast cancerPatricia J Keller, Lisa M Arendt, Adam Skibinski, et al.
Breast Cancer Research and Treatment|December 11, 2012
MicroRNA-30c targets cytoskeleton genes involved in breast cancer cell invasionJessica Bockhorn, Kathy Yee, Ya-Fang Chang, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 3, 2011
Comparative oncogenomics identifies breast tumors enriched in functional tumor-initiating cellsJason I Herschkowitz, Wei Zhao, Mei Zhang, et al.
Journal of the National Cancer Institute|May 14, 2009
Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancerMaggie C U Cheang, Stephen K Chia, David Voduc, et al.
Biorxiv : the Preprint Server for Biology|April 8, 2024
Generative Adversarial Networks Accurately Reconstruct Pan-Cancer Histology from Pathologic, Genomic, and Radiographic Latent FeaturesFrederick M Howard, Hanna M Hieromnimon, Siddhi Ramesh, et al.
Journal of the National Cancer Institute|April 5, 2017
Progesterone Receptor Isoform Ratio: A Breast Cancer Prognostic and Predictive Factor for Antiprogestin ResponsivenessPaola A Rojas, María May, Gonzalo R Sequeira, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 14, 2013
Mutant PIK3CA accelerates HER2-driven transgenic mammary tumors and induces resistance to combinations of anti-HER2 therapiesAriella B Hanker, Adam D Pfefferle, Justin M Balko, et al.
Science Advances|November 15, 2024
Generative adversarial networks accurately reconstruct pan-cancer histology from pathologic, genomic, and radiographic latent featuresFrederick M Howard, Hanna M Hieromnimon, Siddhi Ramesh, et al.
NPJ Breast Cancer|March 8, 2025
Prognostic and molecular multi-platform analysis of CALGB 40603 (Alliance) and public triple-negative breast cancer datasetsBrooke M Felsheim, Aranzazu Fernandez-Martinez, Cheng Fan, et al.
Plos One|May 8, 2013
Pharmacokinetics and efficacy of PEGylated liposomal doxorubicin in an intracranial model of breast cancerCarey K Anders, Barbara Adamo, Olga Karginova, et al.
Pageof 48